Clinical Trial Update: Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and Digoxin [Phase 1]

View source ↗

Summary

Completed Phase 1 trial evaluating potential pharmacokinetic interaction between Lecozotan and Digoxin in Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• DIGOXIN (Digoxin)
• Lecozotan (Lecozotan)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED